Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

91 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mechanism of entry of human rhinovirus 2 into HeLa cells.
Neubauer C, Frasel L, Kuechler E, Blaas D. Neubauer C, et al. Virology. 1987 May;158(1):255-8. doi: 10.1016/0042-6822(87)90264-9. Virology. 1987. PMID: 3033893
Apoptotic events induced by human rhinovirus infection.
Deszcz L, Gaudernak E, Kuechler E, Seipelt J. Deszcz L, et al. J Gen Virol. 2005 May;86(Pt 5):1379-1389. doi: 10.1099/vir.0.80754-0. J Gen Virol. 2005. PMID: 15831950
Antiviral effects of pyrrolidine dithiocarbamate on human rhinoviruses.
Gaudernak E, Seipelt J, Triendl A, Grassauer A, Kuechler E. Gaudernak E, et al. J Virol. 2002 Jun;76(12):6004-15. doi: 10.1128/jvi.76.12.6004-6015.2002. J Virol. 2002. PMID: 12021333 Free PMC article.
An antiviral peptide inhibitor that is active against picornavirus 2A proteinases but not cellular caspases.
Deszcz L, Cencic R, Sousa C, Kuechler E, Skern T. Deszcz L, et al. J Virol. 2006 Oct;80(19):9619-27. doi: 10.1128/JVI.00612-06. J Virol. 2006. PMID: 16973565 Free PMC article.
Seipelt, E. Vassilieva, A. Roetzer, and E. Kuechler, FEBS Lett. 560:51-55, 2004). Here, we describe a derivative of zVAD.fmk that inhibits HRV2 2Apro but that has no effect on caspase 9. ...
Seipelt, E. Vassilieva, A. Roetzer, and E. Kuechler, FEBS Lett. 560:51-55, 2004). Here, we describe a derivative of zVA …
Rhinoviral receptor discrimination: mutational changes in the canyon regions of human rhinovirus types 2 and 14 indicate a different site of interaction.
Duechler M, Ketter S, Skern T, Kuechler E, Blaas D. Duechler M, et al. J Gen Virol. 1993 Oct;74 ( Pt 10):2287-91. doi: 10.1099/0022-1317-74-10-2287. J Gen Virol. 1993. PMID: 8409953
2A proteinase of human rhinovirus cleaves cytokeratin 8 in infected HeLa cells.
Seipelt J, Liebig HD, Sommergruber W, Gerner C, Kuechler E. Seipelt J, et al. J Biol Chem. 2000 Jun 30;275(26):20084-9. doi: 10.1074/jbc.275.26.20084. J Biol Chem. 2000. PMID: 10867028
A neutralizing epitope on human rhinovirus type 2 includes amino acid residues between 153 and 164 of virus capsid protein VP2.
Skern T, Neubauer C, Frasel L, Gründler P, Sommergruber W, Zorn M, Kuechler E, Blaas D. Skern T, et al. J Gen Virol. 1987 Feb;68 ( Pt 2):315-23. doi: 10.1099/0022-1317-68-2-315. J Gen Virol. 1987. PMID: 2434607
Human rhinovirus serotype 2: in vitro synthesis of an infectious RNA.
Duechler M, Skern T, Blaas D, Berger B, Sommergruber W, Kuechler E. Duechler M, et al. Virology. 1989 Jan;168(1):159-61. doi: 10.1016/0042-6822(89)90414-5. Virology. 1989. PMID: 2535899
The eIF4G-eIF4E complex is the target for direct cleavage by the rhinovirus 2A proteinase.
Haghighat A, Svitkin Y, Novoa I, Kuechler E, Skern T, Sonenberg N. Haghighat A, et al. J Virol. 1996 Dec;70(12):8444-50. doi: 10.1128/JVI.70.12.8444-8450.1996. J Virol. 1996. PMID: 8970966 Free PMC article.
91 results
Jump to page
Feedback